Luminex Corp (LMNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

12212 TECHNOLOGY BLVD AUSTIN, TX 78727

The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex accelerates reliable answers while simplifying complexity and deliver certainty with a seamless experience.

Data as of 2021-07-25 16:11:21 -0400
Market Cap0 Shares Outstanding47.314 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0.501
Price/Sales Debt to Equity1.68 EBITDA64.279 Million
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash271.56 Million Current Debt57.563 Million Gross Profit263.967 Million
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date Price to Cash FLow (P/CF) 145.0533
Data provided by IEX Cloud
View SEC Filings from LMNX instead.

View recent insider trading info

Funds Holding LMNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LMNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KEVER JIM D

  • Director
0 2021-07-14 1

ERICKSON THOMAS W

  • Director
0 2021-07-14 1

MCNAMARA KEVIN M

  • Director
0 2021-07-14 1

CURRIE HARRISS T SVP, FINANCE & CFO

  • Officer
0 2021-07-14 3

OGUNRO EDWARD A

  • Director
0 2021-07-14 2

LEWIS DIJUANA K

  • Director
0 2021-07-14 1

SAMET KENNETH A

  • Director
0 2021-07-14 1

REW RICHARD W. II SVP, GEN COUNSEL & CORP SECY

  • Officer
0 2021-07-14 2

SHAMIR NACHUM PRESIDENT & CEO

  • Officer
  • Director
0 2021-07-14 2

FAIRCHILD NANCY SVP, HUMAN RESOURCES

  • Officer
0 2021-07-14 2

MYERS RANDALL SVP, GLOBAL MFG AND QUALITY

  • Officer
0 2021-07-14 2

ECK STEPHEN L.

  • Director
0 2021-07-14 3

BENNETT TODD C. SVP, GLOBAL SALES & CUST OPS

  • Officer
0 2021-07-14 3

SHAPIRO ERIC SR VP, GLOBAL MARKETING

  • Officer
0 2021-07-14 2

COLLINS CHARLES J. SR VP, R&D - US

  • Officer
0 2021-07-14 2

LOEWENBAUM G WALTER II

  • Director
No longer subject to file 2020-08-04 0

CRESCI ROBERT J

  • Director
220,157 2018-05-17 0

LAZARUS TADD S. SVP, CHIEF MEDICAL OFFICER

  • Officer
10,495 2017-03-10 0

JOHNSTON JAY B

  • Director
146,696 2016-05-19 0

BRADLEY RUSSELL W SVP, CORP DEV & CMO

  • Officer
100,667 2016-03-22 0

GOAD FRED C JR

  • Director
300,767 2015-05-14 0

BRIDGE-COOK JEREMY K SVP, RESEARCH AND DEVELOPMENT

  • Officer
74,273 2015-03-12 0

BALTHROP PATRICK J PRESIDENT & CEO

  • Officer
  • Director
646,873 2014-05-14 0

REITER DAVID S SVP & GENERAL COUNSEL

  • Officer
60,400 2014-05-01 0

PINTEK MICHAEL F SVP, OPERATIONS

  • Officer
62,236 2014-03-13 0

DEHNE TIMOTHY R VP, SYSTEMS R&D

  • Officer
20,441 2013-08-16 0

VAILLANT GERARD

  • Director
61,842 2012-05-23 0

GOSCH GREGORY J VP, BIOSCIENCE GROUP

  • Officer
55,380 2010-05-13 0

THOMPSON J STARK PHD

  • Director
18,289 2008-11-26 0

CARRANO JOHN C VP, RESEARCH & DEVELOPMENT

  • Officer
43,913 2008-11-17 0

BRYANT DOUGLAS C EVP, CHIEF OPERATING OFFICER

  • Officer
68,428 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LUMINEX CORP LMNX 2021-07-14 22:15:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 21:45:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 21:15:03 UTC -0.1729 0.2529 2400000
LUMINEX CORP LMNX 2021-07-14 20:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 20:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 19:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 19:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 18:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 18:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 17:45:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 17:15:03 UTC -0.1739 0.2539 2400000
LUMINEX CORP LMNX 2021-07-14 16:45:04 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 16:15:03 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 15:45:02 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 15:15:03 UTC -0.1751 0.2551 2400000
LUMINEX CORP LMNX 2021-07-14 14:45:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 14:15:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 13:45:03 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 13:15:02 UTC -0.2023 0.2823 2400000
LUMINEX CORP LMNX 2021-07-14 12:45:02 UTC -0.2023 0.2823 2400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Defensive Long Fund LMNX -105.0 shares, $-2890.65 2020-03-31 N-PORT

Elevate your investments